SMALL-VESSEL VASCULITIS STUDIES

If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu

ABROGATE: Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non Severe, GPA 

Medication involved: YES

Disease studied: GPA

Currently enrolling: YES

MANDARA: Benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA)

Medication involved: YES

Disease studied: EGPA

Currently enrolling: YES

NMB: Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis

Medication involved: NO

Disease studied: GPA, MPA, EGPA, & RP

Currently enrolling: YES (EGPA, RP)

The EGPA Registry

Medication involved: NO

Disease studied: EGPA

Currently enrolling: YES

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)

Medication involved: YES

Disease studied: GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN

Currently enrolling: YES

One-Time DNA Study for Vasculitis

Medication involved: NO

Disease studied: GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN

Currently enrolling: YES 

The Assessment of Prednisone in Remission Trial (TAPIR)

Medication involved: YES

Disease studied: GPA

Currently enrolling: YES

A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS)

Medication involved: YES

Disease studied: Cutaneous small/medium vessel vasculitis, cPAN, or IgA vasculitis

Currently enrolling: YES

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Medication involved: NO

Disease studied: GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial

Currently enrolling: YES

Tissue Repository Collection Protocol

Medication involved: NO

Disease studied: GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis

Currently enrolling: YES